Citation Impact
Citing Papers
Functional specialization of β-arrestin interactions revealed by proteomic analysis
2007 StandoutNobel
Directed evolution of cytochrome c for carbon–silicon bond formation: Bringing silicon to life
2016 StandoutScienceNobel
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Genome-wide features of neuroendocrine regulation in Drosophila by the basic helix-loop-helix transcription factor DIMMED
2015 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
The mystery of nonclassical protein secretion
2003
Caveolin-1 Is a Negative Regulator of Caveolae-mediated Endocytosis to the Endoplasmic Reticulum
2002
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Differential Kinetic and Spatial Patterns of β-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II Receptor
2004 StandoutNobel
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Calcineurin Promotes Hypoxia-inducible Factor 1α Expression by Dephosphorylating RACK1 and Blocking RACK1 Dimerization
2007 StandoutNobel
Galectins as modulators of tumour progression
2005
Regulated portals of entry into the cell
2003 StandoutNature
Expanding the Enzyme Universe: Accessing Non‐Natural Reactions by Mechanism‐Guided Directed Evolution
2015 StandoutNobel
Tumor Hypoxia and Malignant Progression
2004
Molecular mechanisms of cisplatin resistance
2011 Standout
The central neuropharmcology of psychotropic cannabinoids
1988
Carbohydrate triazoles and isoxazoles as inhibitors of galectins-1 and -3
2006
Synthesis and evaluation of a new inhibitor of phosphoglucose isomerases: the enediolate analogue 5-phospho-D-arabinohydroxamate
1998
Tumor interactions with the vasculature: angiogenesis and tumor metastasis
1990
A new chemical probe for the detection of the cancer-linked galectin-3
2006
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
AUTOCRINE AND PARACRINE REGULATION BY CYTOKINES AND GROWTH FACTORS IN MELANOMA
2000
GlcNAc 2-Epimerase Can Serve a Catabolic Role in Sialic Acid Metabolism
2003 StandoutNobel
Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death
1998
The Fas Death Factor
1995 StandoutScience
Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix
1994 StandoutNobel
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Enzymes with extra talents: moonlighting functions and catalytic promiscuity
2003
The role of phosphatidylserine in recognition of apoptotic cells by phagocytes
1998
Multifaceted roles of glycolytic enzymes
2005
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
1998 StandoutNature
CED-1 Is a Transmembrane Receptor that Mediates Cell Corpse Engulfment in C. elegans
2001 StandoutNobel
Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression
1987
Metabolic dysregulation in monogenic disorders and cancer — finding method in madness
2015
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Flow cytometry‐assisted purification and proteomic analysis of the corticotropes dense‐core secretory granules
2008
Cancer-related inflammation
2008 StandoutNature
Development of novel therapeutic strategies that target HIF-1
2006 StandoutNobel
3-(1,2,3-Triazol-1-yl)-1-thio-galactosides as small, efficient, and hydrolytically stable inhibitors of galectin-3
2005
Autocrine Motility Factor Signaling Enhances Pancreatic Cancer Metastasis
2004
Investigating Cell Surface Galectin-Mediated Cross-Linking on Glycoengineered Cells
2012 StandoutNobel
Functional rafts in cell membranes
1997 StandoutNature
Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism.
1990
CTLA-4 blockade synergizes with tumor-derived granulocyte– macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma
1998 StandoutNobel
In the light of directed evolution: Pathways of adaptive protein evolution
2009 StandoutNobel
Regulation of Cytokine Receptors by Golgi N-Glycan Processing and Endocytosis
2004 Science
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
2011 StandoutNobel
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
Hypoxia-Inducible Factor 1 and Cardiovascular Disease
2013 StandoutNobel
A Self-Assembled Multivalent Pseudopolyrotaxane for Binding Galectin-1
2004 StandoutNobel
Apoptosis and Programmed Cell Death in Immunity
1992
Membrane Cholesterol, Tumorigenesis, and the Biochemical Phenotype of Neoplasia
1981
Functions of Ceramide in Coordinating Cellular Responses to Stress
1996 StandoutScience
T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28
1996
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression.
1987
Metabolic reprogramming and cancer progression
2020 StandoutScience
Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions.
1990
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
2010
Growth Factors and Cancer
1991 StandoutScience
The Molecular Genetics of Cancer
1987 StandoutScienceNobel
Nuclear repartitioning of galectin-1 by an extracellular glycan switch regulates mammary morphogenesis
2016 StandoutNobel
Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1.
2003 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice.
1985
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
1992 StandoutScience
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
Tumor-induced immune dysfunction: the macrophage connection
1998
Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity.
1990
Galectins. Structure and function of a large family of animal lectins.
1994
Cytosolic Ca2+ homeostasis in Ehrlich and Yoshida carcinomas. A new, membrane-permeant chelator of heavy metals reveals that these ascites tumor cell lines have normal cytosolic free Ca2+.
1985 StandoutNobel
Biological Diversity in Metastatic Neoplasms: Origins and Implications
1982 Science
Regulation of Cell Motility by Mitogen-activated Protein Kinase
1997
Direct visualization of redistribution and capping of fluorescent gangliosides on lymphocytes.
1984
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Cu-Catalyzed Azide−Alkyne Cycloaddition
2008 StandoutNobel
Identification of Galectin-3 As a High-Affinity Binding Protein for Advanced Glycation End Products (AGE): A New Member of the AGE-Receptor Complex
1995
Unconventional Secretion, Unconventional Solutions
2013 StandoutScienceNobel
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
1994 StandoutScience
Apoptosis in AIDS
1993 StandoutScienceNobel
Gangliosides as receptors for fibronectin?
1982
Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart
2013 StandoutNobel
New Perspectives in Cell Adhesion: RGD and Integrins
1987 StandoutScience
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
1999 StandoutNobel
Works of A. Raz being referenced
Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment
2010
Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer
1996
Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells
2001
Inhibition of Spontaneous Metastasis in a Rat Prostate Cancer Model by Oral Administration of Modified Citrus Pectin
1995
On the role of galectin-3 in cancer apoptosis
2005
Interferon‐gamma treatment of B16 melanoma cells: Opposing effects for non‐adaptive and adaptive immune defense and its reflection by metastatic spread
1988
Identification of Human Melanoma Cellular and Secreted Ligands for Galectin-3
1994
Actin Organization, Cell Motility, and Metastasis
1988
Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells
2002
Decrease in 5'-nucleotidase activity in malignant transformed and normal stimulated cells.
1978
Isolation of plasma membrane fragments and vesicles from ascites fluid of lymphoma-bearing mice and their possible role in the escape mechanism of tumors from host immune rejection
1978
The interaction of hashish components with human erythrocytes
1972
Expression of ki‐ras oncogene in tumor cell variants exhibiting different metastatic capabilities
1985
In Vivo Isolation of a Metastatic Tumor Cell Variant Involving Selective and Nonadaptive Processes<xref ref-type="fn" rid="fn2">2</xref>, <xref ref-type="fn" rid="fn3">3</xref>
1981
Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.
1980
Effect of hashish compounds on mouse peritoneal macrophages.
1976
Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion.
1996
Murine melanoma: a model for intracranial metastasis
1980
Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas.
1994
The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells.
1999
Antibodies to ganglioside GM1 induce mitogenic stimulation and cap formation in rat thymocytes
1978
The effects of experimental conditions on the expression of in vitro-mediated tumor cytotoxicity mediated by murine macrophages
1979
Oncogenicity and immunogenicity associated with membranes isolated from cell-free ascites fluid of lymphoma-bearing mice.
1978
The effect of hashish compounds on phospholipid phase transition
1976
Expression of two different endogenous galactoside-binding lectins sharing sequence homology.
1988
Increased invasive, chemotactic and locomotive abilities of c-Ha-ras-transformed human breast epithelial cells.
1991
Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high- and low-metastatic K1735 melanoma cell variants.
1994
Identification of the metastasis-associated, galactoside-binding lectin as a chimeric gene product with homology to an IgE-binding protein.
1989
Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.
1996
Molecular cloning and chromosomal mapping of a human galactoside-binding protein.
1991
Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells.
1998